141 related articles for article (PubMed ID: 12835641)
1. [Meaning and etiopathogenesis of sectorial transient hepatic attenuation differences (THAD)].
Colagrande S; Centi N; Carmignani L; Salvatore Politi L; Villari N
Radiol Med; 2003 Mar; 105(3):180-7. PubMed ID: 12835641
[TBL] [Abstract][Full Text] [Related]
2. Transient hepatic attenuation differences (THAD) not connected to focal lesions.
Colagrande S; Carmignani L; Pagliari A; Capaccioli L; Villari N
Radiol Med; 2002; 104(1-2):25-43. PubMed ID: 12386553
[TBL] [Abstract][Full Text] [Related]
3. Transient hepatic attenuation difference (THAD) in patients without neoplasm: frequency, shape, distribution, and causes.
Yamasaki M; Furukawa A; Murata K; Morita R
Radiat Med; 1999; 17(2):91-6. PubMed ID: 10399775
[TBL] [Abstract][Full Text] [Related]
4. Transient hepatic attenuation differences and focal liver lesions: sump effect due to primary arterial hyperperfusion.
Colagrande S; Centi N; Pradella S; Duranti B; Belli G; Villari N
J Comput Assist Tomogr; 2009; 33(2):259-65. PubMed ID: 19346856
[TBL] [Abstract][Full Text] [Related]
5. Transient hepatic attenuation differences at biphasic spiral CT examinations.
Köseoğlu K; Taşkin F; Ozsunar Y; Cildağ B; Karaman C
Diagn Interv Radiol; 2005 Jun; 11(2):96-101. PubMed ID: 15957096
[TBL] [Abstract][Full Text] [Related]
6. Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation.
Brancatelli G; Baron RL; Peterson MS; Marsh W
AJR Am J Roentgenol; 2003 Apr; 180(4):1007-14. PubMed ID: 12646446
[TBL] [Abstract][Full Text] [Related]
7. Transient hepatic attenuation difference (THAD) in biliary duct disease.
Pradella S; Centi N; La Villa G; Mazza E; Colagrande S
Abdom Imaging; 2009; 34(5):626-33. PubMed ID: 18682878
[TBL] [Abstract][Full Text] [Related]
8. Nontumorous arterioportal shunt mimicking hypervascular tumor in cirrhotic liver: two-phase spiral CT findings.
Kim TK; Choi BI; Han JK; Chung JW; Park JH; Han MC
Radiology; 1998 Sep; 208(3):597-603. PubMed ID: 9722834
[TBL] [Abstract][Full Text] [Related]
9. Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT.
Byun JH; Kim TK; Lee CW; Lee JK; Kim AY; Kim PN; Ha HK; Lee MG
Radiology; 2004 Aug; 232(2):354-60. PubMed ID: 15215556
[TBL] [Abstract][Full Text] [Related]
10. Multislice Computed Tomographic Manifestation of Transient Hepatic Attenuation Difference in the Left Lobe of the Liver: A Retrospective Study.
Yang B; Si G; He Q; Liu S; Wang S; Xian R; Zhang J; Yu F; Guan J
Adv Ther; 2020 Sep; 37(9):3954-3966. PubMed ID: 32715380
[TBL] [Abstract][Full Text] [Related]
11. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
12. Small (< or = 2 cm) atypical hepatic haemangiomas in the non-cirrhotic patient: pattern-based classification scheme for enhancement at triple-phase helical CT.
Scialpi M; Volterrani L; Mazzei MA; Cappabianca S; Barberini F; Piscioli I; Brunese L; Lupattelli L
Radiol Med; 2009 Sep; 114(6):935-47. PubMed ID: 19579014
[TBL] [Abstract][Full Text] [Related]
13. Nontumorous low-attenuation defects in the liver on helical CT during arterial portography: frequency, location, and appearance.
Bluemke DA; Soyer P; Fishman EK
AJR Am J Roentgenol; 1995 May; 164(5):1141-5. PubMed ID: 7717221
[TBL] [Abstract][Full Text] [Related]
14. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
15. Preoperative evaluation of hepatocellular carcinoma: combined use of CT with arterial portography and hepatic arteriography.
Kim HC; Kim TK; Sung KB; Yoon HK; Kim PN; Ha HK; Kim AY; Kim HJ; Lee MG
AJR Am J Roentgenol; 2003 Jun; 180(6):1593-9. PubMed ID: 12760926
[TBL] [Abstract][Full Text] [Related]
16. Hepatic perfusion abnormalities in acute pancreatitis: CT appearance and clinical importance.
Arita T; Matsunaga N; Takano K; Hara A; Fujita T; Honjo K
Abdom Imaging; 1999; 24(2):157-62. PubMed ID: 10024402
[TBL] [Abstract][Full Text] [Related]
17. Multiple non-tumorous arterioportal shunts due to chronic liver disease mimicking hepatocellular carcinoma: outcomes and the associated elevation of alpha-fetoprotein.
Takayasu K; Muramatsu Y; Mizuguchi Y; Moriyama N; Okusaka T
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):288-94. PubMed ID: 16460488
[TBL] [Abstract][Full Text] [Related]
18. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of transient hepatic attenuation differences on computed tomography scans for acute cholangitis in patients with malignant disease.
Sugishita T; Higuchi R; Morita S; Ota T; Yamamoto M
J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):669-75. PubMed ID: 24816796
[TBL] [Abstract][Full Text] [Related]
20. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms.
Hollett MD; Jeffrey RB; Nino-Murcia M; Jorgensen MJ; Harris DP
AJR Am J Roentgenol; 1995 Apr; 164(4):879-84. PubMed ID: 7726040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
